Research article · 15 Jul 2023
Conference abstract
Chemotherapy-induced peripheral neurotoxicity
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Treatment of solid and hematological malignancies is still largely based on systemic chemotherapy, alone or in combination with surgery and or radiation treatment. In parallel with the improvement in anti-cancer therapy, the management of several among its most serious side effects became easier. However, other chemotherapy-related toxicities emerged as major clinical problems, sometimes requiring anticancer treatment modification or even withdrawal. Among them damage of the peripheral nervous system is particularly frequent and potentially severe after the administration of several widely-used compounds such as platinum-drugs, antitubulins, immunomodulatory drugs and proteasome inhibitors. In view of a scenario showing higher efficacy of anti-cancer therapy leading to a high number of cancer-survivors, the relevance of long-lasting or permanent side effects has also become increasingly important, being chemotherapy-induced peripheral neurotoxicity (CIPN) one of the most severe for its impact on treated subjectsâ?? quality of life. Moreover, CIPN is associated with a remarkable increase in direct and indirect health-related cost in cancer patients. The most common entry sites into peripheral nervous system used by anticancer drugs are dorsal root ganglia and this might explain why sensory impairment is the most common clinical feature of CIPN. However, variable association with motor or autonomic damage is typical of the different drugs types. Moreover, neuropathic pain may be a common symptom, particularly with some of these compounds which are particularly toxic on small nerve fibers as it can be reproduced in relevant animal models.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 29 Aug 2020
Pretreatment with Duloxetine May Prevent Chemotherapy-Induced Neuropathic Pain: A Pilot Study
Research article · 2020
A Pilot Study to Determine the Extent of Chemotherapy-Induced Polyneuropathy (CIPNP) in Breast Cancer Patients
Conference abstract
Ginsenoside rg1 prevents chemotherapy-induced cognitive impairment by suppressing neuroinflammation and promoting neuroplasticity
Opinion · 19 Sep 2024
Chemotherapy-Induced Neurotoxicity: Understanding the Effects on the Nervous System
More from this journal
The newest in Brain Disorders & Therapy.
Article · 10 Jun 2026
Migraine: Understanding Its Causes, Symptoms, and Management
Article · 10 Jun 2026
Brain Network Dysfunction: How Altered Neural Communication Affects Health
Article · 10 Jun 2026
Mitochondrial Encephalopathy: Understanding Energy Failure in the Nervous System
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBrain Disorders & Therapy
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Guido Cavaletti”

